1. Jubashi T, Nagai K, Miyazaki Y, Nakamura H, Matsuo T, Kuriyama K, et al. A unique case of t(15;17) acute promyelocytic leukaemia (M3) developing into acute myeloblastic leukemia (M1) with t(7;21) at relapse. Br J Haematol. 1993; 83:665–668. PMID:
8518183.
2. Hatzis T, Standen GR, Howell RT, Savill C, Wagstaff M, Scott GL. Acute promyelocytic leukemia (M3): relapse with acute myeloblastic leukaemia (M2) and dic(5;17)(q11;p11). Am J Hematol. 1995; 48:40–44. PMID:
7832190.
3. Sawada H, Morimoto H, Wake A, Yamasaki Y, Izumi Y. Therapy-related acute myeloid leukemia with t(10;11)(q23;p15) following successful chemotherapy for acute promyelocytic leukemia with t(15;17)(q22;q21). Int J Hematol. 1999; 69:270–271. PMID:
10407587.
4. Zompi S, Legrand O, Bouscary D, Blanc CM, Picard F, Casadevall N, et al. Therapy-related acute myeloid leukaemia after successful therapy for acute promyelocytic leukaemia with t(15;17): a report of two cases and a review of the literature. Br J Haematol. 2000; 110:610–613. PMID:
10997972.
Article
5. Latagliata R, Petti MC, Fenu S, Mancini M, Spiriti MA, Breccia M, et al. Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem. Blood. 2002; 99:822–824. PMID:
11806982.
Article
6. Athanasiadou A, Saloum R, Zorbas I, Tsompanakou A, Batsis I, Fassas A, et al. Therapy-related myelodysplastic syndrome with monosomy 5 and 7 following successful therapy for acute promyelocytic leukemia with anthracyclines. Leuk Lymphoma. 2002; 43:2409–2411. PMID:
12613533.
Article
7. Zompi S, Viguié F. Therapy-related acute myeloid leukemia and myelodysplasia after successful treatment of acute promyelocytic leukemia. Leuk Lymphoma. 2002; 43:275–280. PMID:
11999558.
Article
8. Lee GY, Christina S, Tien SL, Ghafar AB, Hwang W, Lim LC, et al. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia. Cancer Genet Cytogenet. 2005; 159:129–136. PMID:
15899384.
Article
9. Park TS, Choi JR, Yoon SH, Song J, Kim J, Kim SJ, et al. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript. Cancer Genet Cytogenet. 2008; 187:61–73. PMID:
19027486.
Article
10. Batzios C, Hayes LA, He SZ, Quach H, McQuilten ZK, Wall M, et al. Secondary clonal cytogenetic abnormalities following successful treatment of acute promeylocytic leukemia. Am J Hematol. 2009; 84:715–719. PMID:
19806661.
11. Betancourt-García RD, Castro J, Fernández AC, López-Enríquez A, Fradera J, Pacheco E. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature. P R Health Sci J. 2009; 28:146–150. PMID:
19530558.
12. Montesinos P, González JD, González J, Rayón C, de Lisa E, Amigo ML, et al. Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic Acid and anthracycline-based chemotherapy. J Clin Oncol. 2010; 28:3872–3879. PMID:
20625122.
Article
13. Ojeda-Uribe M, Schneider A, Luquet I, Berceanu A, Cornillet-Lefebvre P, Jeandidier E, et al. Therapy-related acute myeloid leukemia (t-AML) with poor-risk cytogenetics in two patients with persistent molecular complete remission of acute promyelocytic leukemia. Eur J Haematol. 2012; 89:267–272. PMID:
22591288.
Article
14. Garcia-Manero G, Kantarjian HM, Kornblau S, Estey E. Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL). Leukemia. 2002; 16:1888. PMID:
12200720.
Article